LONG-TERM TREATMENT OUTCOMES AFTER BEVACIZUMAB THERAPY FOR MACULAR NEOVASCULARIZATION IN WHITE PATIENTS WITH HIGH MYOPIA.

Publication Year: 2022

DOI:
10.1097/IAE.0000000000003675

PMCID:
PMC9935556

PMID:
36395427

Journal Information

Full Title: Retina

Abbreviation: Retina

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"None of the authors has any financial/conflicting interests to disclose."

Evidence found in paper:

"Supported by Oogfonds, Landelijke Stichting voor Blinden en Slechtzienden, Algemene Nederlandse Vereniging Ter Voorkoming Van Blindheid and Stichting Beheer ‘t Schild through Uitzicht (2019-14), Rotterdamse Stichting Blindenbelangen (20190034), and Stichting Wetenschappelijk Onderzoek Oogziekenhuis (2019S06). C. C. W. Klaver obtained funding from Netherlands Organization for Scientific Research (NWO, Grant 91815655), and from European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (Grant 648268)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025